A global perspective on the status of clinical metabolomics in laboratory medicine - a survey by the IFCC metabolomics working group

被引:1
|
作者
Fux, Elie [1 ]
Lenski, Marie [2 ,3 ]
Bendt, Anne K. [4 ]
Otvos, James D. [5 ]
Ivanisevic, Julijana [6 ]
De Bruyne, Sander [7 ]
Cavalier, Etienne [8 ]
Friedecky, David [9 ,10 ]
机构
[1] Roche Diagnost GmbH, Nonnenwald 2, Penzberg, Germany
[2] Univ Lille, IMPECS IMPact Environm Chim Sante Humaine, CHU Lille, Inst Pasteur Lille,ULR 4483, F-59000 Lille, France
[3] CHU Lille, Unite Fonct Toxicol, Lille, France
[4] Natl Univ Singapore, Life Sci Inst, Singapore Lipid Incubator, Singapore, Singapore
[5] NHLBI, NIH, Translat Vasc Med Branch, Lipoprot Metab Lab, Bethesda, MD USA
[6] Univ Lausanne, Fac Biol & Med, Metabol Unit, Lausanne, Switzerland
[7] Ghent Univ Hosp, Dept Lab Med, Ghent, Belgium
[8] Univ Liege, CHU Liege, Dept Clin Chem, CIRM, Liege, Belgium
[9] Univ Hosp Olomouc, Dept Clin Biochem, Zdravotniku 7, Olomouc 77900, Czech Republic
[10] Palacky Univ Olomouc, Fac Med & Dent, Olomouc, Czech Republic
关键词
clinical metabolomics; clinical lipidomics; emerging technologies; diagnostics; prognostics; laboratory medicine; CORONARY-ARTERY-DISEASE; CERAMIDES; TOOL;
D O I
10.1515/cclm-2024-0550
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Metabolomics aims for comprehensive characterization and measurement of small molecule metabolites (<1700 Da) in complex biological matrices. This study sought to assess the current understanding and usage of metabolomics in laboratory medicine globally and evaluate the perception of its promise and future implementation. Methods: A survey was conducted by the IFCC metabolomics working group that queried 400 professionals from 79 countries. Participants provided insights into their experience levels, knowledge, and usage of metabolomics approaches, along with detailing the applications and methodologies employed. Results: Findings revealed a varying level of experience among respondents, with varying degrees of familiarity and utilization of metabolomics techniques. Targeted approaches dominated the field, particularly liquid chromatography coupled to a triple quadrupole mass spectrometer, with untargeted methods also receiving significant usage. Applications spanned clinical research, epidemiological studies, clinical diagnostics, patient monitoring, and prognostics across various medical domains, including metabolic diseases, endocrinology, oncology, cardiometabolic risk, neurodegeneration and clinical toxicology. Conclusions: Despite optimism for the future of clinical metabolomics, challenges such as technical complexity, standardization issues, and financial constraints remain significant hurdles. The study underscores the promising yet intricate landscape of metabolomics in clinical practice, emphasizing the need for continued efforts to overcome barriers and realize its full potential in patient care and precision medicine.
引用
收藏
页码:1950 / 1961
页数:12
相关论文
共 50 条
  • [31] Laboratory medicine meets precision medicine: The paradigm of metabolomics in perinatology Proposals from the 4th International Conference on Neonatal and Pediatric Laboratory Medicine
    Mussap, Michele
    Ferrari, Maurizio
    Fanos, Vassilios
    CLINICA CHIMICA ACTA, 2015, 451 : 1 - 3
  • [32] IFCC reference procedures for measurement of the catalytic concentrations of enzymes: corrigendum, notes and useful advice International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) - IFCC Scientific Division
    Schumann, Gerhard
    Canalias, Francesca
    Joergensen, Poul J.
    Kang, Dongchon
    Lessinger, Jean-Marc
    Klauke, Rainer
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (05) : 615 - 621
  • [33] Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine
    Kohler, Isabelle
    Hankemeier, Thomas
    van der Graaf, Piet H.
    Knibbe, Catherijne A. J.
    van Hasselt, J. G. Coen
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 109 : S15 - S21
  • [34] The value of global metabolomics in association with clinical factors for diagnosis of renal cell carcinoma
    Sato, Tomonori
    Kawasaki, Yoshihide
    Maekawa, Masamitsu
    Takasaki, Shinya
    Mitsuzuka, Koji
    Ito, Akihiro
    Yamamoto, Masayuki
    Arai, Yoichi
    CANCER SCIENCE, 2018, 109 : 933 - 933
  • [35] Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - A view from the IFCC Working Group for PTH
    Sturgeon, Catharine M.
    Sprague, Stuart
    Almond, Alison
    Cavalier, Etienne
    Fraser, William D.
    Algeciras-Schimnich, Alicia
    Singh, Ravinder
    Souberbielle, Jean-Claude
    Vesper, Hubert W.
    CLINICA CHIMICA ACTA, 2017, 467 : 42 - 47
  • [36] Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey
    Loh, Tze Ping
    Horvath, Andrea Rita
    Wang, Cheng-Bin
    Koch, David
    Lippi, Giuseppe
    Mancini, Nicasio
    Ferrari, Maurizio
    Hawkins, Robert
    Sethi, Sunil
    Adeli, Khosrow
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (09) : 1433 - 1440
  • [37] A worldwide paediatric laboratory medicine network: the International Federation of Clinical Chemistry Task Force on Pediatric Laboratory Medicine (IFCC TF-PLM)
    Kohse, Klaus P.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (03) : 193 - 194
  • [38] Herbal Medicine: Clinical Perspective & Regulatory Status
    Barkat, Md Abul
    Goyal, Anjali
    Barkat, Harshita A.
    Salauddin, Mohammad
    Pottoo, Faheem H.
    Anwer, Esra T.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2021, 24 (10) : 1573 - 1582
  • [39] GLOBAL METABOLOMICS FOR PRECISION MEDICINE: GAIN INSIGHTS ON GENE PENETRANCE, EARLY DIAGNOSIS, AND DRUG RESPONSES
    Joensson, Thomas
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S13 - S13
  • [40] The European Laboratory Working Group on Diphtheria: A global microbiologic network
    Efstratiou, A
    Roure, C
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 : S146 - S151